Warning! I think this FTSE 100 dividend stock will keep falling in 2020

This fast-growing FTSE 100 (INDEXFTSE: UKX) business came under attack before Christmas.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shareholders of FTSE 100 hospital operator NMC Health (LSE: NMC) saw the value of their stock fall by more than 30% in the week before Christmas after US short seller Muddy Waters released a highly critical report on the firm.

Muddy Waters’ report contains allegations of accounting irregularities. NMC has strenuously denied any such irregularities, but I suspect that many investors will be concerned about this situation and unsure how to act.

In this article I’m going to take a broader look at NMC and give my view on the stock. I’ll also consider the outlook for another FTSE 100 stock with a strong track record of growth.

What’s the story?

NMC Health is the largest private healthcare operator in the UAE. According to the firm, it’s also “amongst the leading fertility service providers in the world”. Last year, 87.6% of revenue came from the UAE. The remainder came from a mix of operations in Western Europe and elsewhere in the Middle East.

NMC is 46 years old, but only listed on the London Stock Exchange in 2012. This listing was followed by explosive growth that saw the group’s revenue quadruple from $551m in 2013 to $2,057m in 2018.

Profits rose by 265% from $69.1m to $252m over the same period, and between January 2013 and December 2018, the share price rose by 1,289%!

Although it’s publicly listed, 51% of the group’s shares are held by three individuals, including two board directors. This suggests to me that smaller investors, including UK fund managers, are unlikely to have much influence on how the company is run.

Should you buy NMC?

The firm has made a lot of money for early investors who held on to their shares. But the group’s rapid expansion has been fuelled by debt — my analysis shows that net debt has risen from $63.7m to $1,521m since 2013.

In fairness, this business does seem to generate plenty of cash. But it spends a lot too. I’m concerned about what will happen when the group’s double-digit annual growth rate starts to slow.

The stock’s recent fall has left it looking more reasonably valued, on about 15 times 2019 forecast earnings.

However, I feel that the firm’s high degree of leverage and its overseas focus add risk for UK investors and make the outlook harder to assess. I’ve put this stock in the ‘too difficult’ pile and will continue to avoid it in 2020.

One stock I’ve been buying

I’m more bullish about cruise ship operator Carnival (LSE: CCL). This FTSE 100 firm is the largest company in this fast-growing sector, but the Carnival share price has fallen by 25% over the last two years.

Rising costs and one-off political events have hit the group’s operating margin, which fell by almost 2% to 15.7% last year. However, I still see this as an attractive level of profitability that reflects the group’s market-leading scale.

Looking ahead, the company says that bookings so far for 2020 are at record levels, in terms of occupancy.

I think that the Carnival share price probably got ahead of itself when it peaked at over £50 in 2017. But with the price now hovering around £37, the stock trades on just 11 times forecast earnings with a 4.2% dividend yield. I think this looks decent value. I’ve been adding the shares to my own portfolio in recent months.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares of Carnival. The Motley Fool UK owns shares of and has recommended NMC Health. The Motley Fool UK has recommended Carnival. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »